title: Xeroderma pigmentosum variant: response to etretinate.
abstract: We report a case of the variant form of xeroderma pigmentosum in whom tumour development was completely suppressed for 22 months by etretinate 25 mg daily.
authors.affiliation: Department of Dermatology, Leicester Royal Infirmary, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Berth-Jones
authors.forename: R A
authors.initials: RA
authors.lastname: Graham-Brown
mesh_terms: D004260:DNA Repair / Q000502:physiology; D005050:Etretinate / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000235:genetics; D014983:Xeroderma Pigmentosum / Q000188:drug therapy* / Q000235:genetics
chemical_list: D005050:Etretinate